Lunginnov

0 products

Lunginnov commercializes a range of innovative products for the detection of Endocan/ESM-1 (endothelial cell-specific molecule 1). Endocan has been shown to be an effective biomarker of endothelial activation and dysfunction in a number of disease states including human lung, liver, brain and kidney cancers and in severe sepsis. Lunginnov develops also innovative R&D programs to offer better solutions to investigators involved in vascular dysfunction.